Key result
First-line coronary CTA improves gatekeeping, risk stratification, and clinical outcomes across 5 key areas.
Answers are grounded in this paper and cite their sources.
Review demonstrates clinical utility and diagnostic accuracy of coronary CT angiography in stable chest pain, indicating its readiness as a comprehensive first-line evaluation.
Coronary computed tomography angiography (CCTA) is a validated technique for the evaluation of patients with suspected coronary artery disease, showing high accuracy compared with invasive coronary angiography and high negative predictive value. CCTA is also well positioned as a first-line test for the evaluation of stable chest pain. This purpose of this review is to examine the evidence behind CCTA in the setting of stable chest pain, with attention to 5 key strengths of a CCTA-based approach: (1) effective gatekeeping to cardiac catheterization, (2) selective discrimination for revascularization and tailored medical therapy, (3) advanced risk stratification, (4) improvement in outcomes, and (5) support from multisociety guidelines. Given the expansion of CT technologies to include functional strategies for evaluating ischemia both with and without vasodilators, CCTA is poised to become the comprehensive examination for stable chest pain and anginal equivalent cardiopulmonary symptoms.
No takes yet. Share an insight, caveat, or question.
Maroules et al. (2018) conducted a review in Stable chest pain and suspected coronary artery disease. Coronary computed tomography angiography (CCTA) vs. Invasive coronary angiography was evaluated. Coronary computed tomography angiography offers 5 key strengths as a first-line test for stable chest pain, improving gatekeeping, risk stratification, and clinical outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: